Overview

Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee

Status:
Completed
Trial end date:
2020-09-07
Target enrollment:
Participant gender:
Summary
A Multi-center, Double-blinded, Randomized, Active-controlled, Parallel Design, phaseII Study to Investigate the Efficacy and Safety of YYC301 in Subject With Knee Osteoarthritis
Phase:
Phase 2
Details
Lead Sponsor:
Yooyoung Pharmaceutical Co., Ltd.
Collaborators:
CliPS Co., Ltd
Green Cross Corporation
Treatments:
Celecoxib
Tramadol